Literature DB >> 20143199

Dopamine system dysregulation by the ventral subiculum as the common pathophysiological basis for schizophrenia psychosis, psychostimulant abuse, and stress.

Anthony A Grace1.   

Abstract

The dopamine system is under multiple forms of regulation, and in turn provides effective modulation of system responses. Dopamine neurons are known to exist in several states of activity. The population activity, or the proportion of dopamine neurons firing spontaneously, is controlled by the ventral subiculum of the hippocampus. In contrast, burst firing, which is proposed to be the behaviorally salient output of the dopamine system, is driven by the brainstem pedunculopontine tegmentum (PPTg). When an animal is exposed to a behaviorally salient stimulus, the PPTg elicits a burst of action potentials in the dopamine neurons. However, this bursting only occurs in the portion of the dopamine neuron population that is firing spontaneously. This proportion is regulated by the ventral subiculum. Therefore, the ventral subiculum provides the gain, or the amplification factor, for the behaviorally salient stimulus. The ventral subiculum itself is proposed to carry information related to the environmental context. Thus, the ventral subiculum will adjust the responsivity of the dopamine system based on the needs of the organism and the characteristics of the environment. However, this finely tuned system can be disrupted in disease states. In schizophrenia, a disruption of interneuronal regulation of the ventral subiculum is proposed to lead to an overdrive of the dopamine system, rendering the system in a constant hypervigilant state. Moreover, amphetamine sensitization and stressors also appear to cause an abnormal dopaminergic drive. Such an interaction could underlie the risk factors of drug abuse and stress in the precipitation of a psychotic event. On the other hand, this could point to the ventral subiculum as an effective site of therapeutic intervention in the treatment or even the prevention of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20143199      PMCID: PMC2932888          DOI: 10.1007/s12640-010-9154-6

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  103 in total

1.  Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.

Authors:  Louise Arseneault; Mary Cannon; Richie Poulton; Robin Murray; Avshalom Caspi; Terrie E Moffitt
Journal:  BMJ       Date:  2002-11-23

2.  Basolateral amygdala efferents to the ventral subiculum preferentially innervate pyramidal cell dendritic spines.

Authors:  Sarah Jane French; Julia Catherine Hailstone; Susan Totterdell
Journal:  Brain Res       Date:  2003-08-15       Impact factor: 3.252

3.  Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission.

Authors:  Stan B Floresco; Anthony R West; Brian Ash; Holly Moore; Anthony A Grace
Journal:  Nat Neurosci       Date:  2003-09       Impact factor: 24.884

4.  What does the Edinburgh high-risk study tell us about schizophrenia?

Authors:  Eve C Johnstone; Stephen M Lawrie; Richard Cosway
Journal:  Am J Med Genet       Date:  2002-12-08

5.  Working memory deficits in adult rats after prenatal disruption of neurogenesis.

Authors:  R Gourevitch; C Rocher; G Le Pen; M-O Krebs; T M Jay
Journal:  Behav Pharmacol       Date:  2004-07       Impact factor: 2.293

6.  The prefrontal cortex regulates lateral amygdala neuronal plasticity and responses to previously conditioned stimuli.

Authors:  J Amiel Rosenkranz; Holly Moore; Anthony A Grace
Journal:  J Neurosci       Date:  2003-12-03       Impact factor: 6.167

7.  Disruption of neurogenesis on gestational day 17 in the rat causes behavioral changes relevant to positive and negative schizophrenia symptoms and alters amphetamine-induced dopamine release in nucleus accumbens.

Authors:  Peter Flagstad; Arne Mørk; Birte Y Glenthøj; Johan van Beek; Adina T Michael-Titus; Michael Didriksen
Journal:  Neuropsychopharmacology       Date:  2004-11       Impact factor: 7.853

8.  Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis.

Authors:  C K Chen; S K Lin; P C Sham; D Ball; E W Loh; C C Hsiao; Y L Chiang; S C Ree; C H Lee; R M Murray
Journal:  Psychol Med       Date:  2003-11       Impact factor: 7.723

9.  Reduced oscillatory gamma-band responses in unmedicated schizophrenic patients indicate impaired frontal network processing.

Authors:  Jürgen Gallinat; Georg Winterer; Christoph S Herrmann; Daniel Senkowski
Journal:  Clin Neurophysiol       Date:  2004-08       Impact factor: 3.708

10.  Induced oscillations and the distributed cortical sources during the Wisconsin card sorting test performance in schizophrenic patients: new clues to neural connectivity.

Authors:  J A González-Hernández; I Cedeño; C Pita-Alcorta; L Galán; E Aubert; P Figueredo-Rodríguez
Journal:  Int J Psychophysiol       Date:  2003-04       Impact factor: 2.997

View more
  43 in total

Review 1.  Emerging, reemerging, and forgotten brain areas of the reward circuit: Notes from the 2010 Motivational Neural Networks conference.

Authors:  Vincent B McGinty; Benjamin Y Hayden; Sarah R Heilbronner; Eric C Dumont; Steven M Graves; Martine M Mirrione; Johann du Hoffmann; Gregory C Sartor; Rodrigo A España; E Zayra Millan; Alexandra G Difeliceantonio; Nathan J Marchant; T Celeste Napier; David H Root; Stephanie L Borgland; Michael T Treadway; Stan B Floresco; Jacqueline F McGinty; Suzanne Haber
Journal:  Behav Brain Res       Date:  2011-07-26       Impact factor: 3.332

2.  Abnormal stress responsivity in a rodent developmental disruption model of schizophrenia.

Authors:  Eric C Zimmerman; Mark Bellaire; Samuel G Ewing; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2013-05-08       Impact factor: 7.853

3.  Evidence for an anterior-posterior differentiation in the human hippocampal formation revealed by meta-analytic parcellation of fMRI coordinate maps: focus on the subiculum.

Authors:  Henry W Chase; Mareike Clos; Sofia Dibble; Peter Fox; Anthony A Grace; Mary L Phillips; Simon B Eickhoff
Journal:  Neuroimage       Date:  2015-03-14       Impact factor: 6.556

Review 4.  Stress and neurodevelopmental processes in the emergence of psychosis.

Authors:  C W Holtzman; H D Trotman; S M Goulding; A T Ryan; A N Macdonald; D I Shapiro; J L Brasfield; E F Walker
Journal:  Neuroscience       Date:  2013-01-05       Impact factor: 3.590

5.  A novel α5GABA(A)R-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia.

Authors:  Kathryn M Gill; Daniel J Lodge; James M Cook; Shamim Aras; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2011-05-11       Impact factor: 7.853

6.  Antipsychotic drugs rapidly induce dopamine neuron depolarization block in a developmental rat model of schizophrenia.

Authors:  Ornella Valenti; Pierangelo Cifelli; Kathryn M Gill; Anthony A Grace
Journal:  J Neurosci       Date:  2011-08-24       Impact factor: 6.167

7.  Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals.

Authors:  Paul Allen; Judy Luigjes; Oliver D Howes; Alice Egerton; Kazuyuki Hirao; Isabel Valli; Joseph Kambeitz; Paolo Fusar-Poli; Matthew Broome; Philip McGuire
Journal:  Schizophr Bull       Date:  2012-01-30       Impact factor: 9.306

8.  Lower Fractional Anisotropy in the Gray Matter of Amygdala-Hippocampus-Nucleus Accumbens Circuit in Methamphetamine Users: an In Vivo Diffusion Tensor Imaging Study.

Authors:  Yadi Li; Wenhua Zhou; Haibo Dong; Wenwen Shen; Jianbing Zhang; Feng Li; Lingjun Zhang
Journal:  Neurotox Res       Date:  2017-10-16       Impact factor: 3.911

Review 9.  Epigenetics and biomarkers in the staging of neuropsychiatric disorders.

Authors:  Trevor Archer; Richard J Beninger; Tomas Palomo; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

10.  Dopamine synthesis and D3 receptor activation in pancreatic β-cells regulates insulin secretion and intracellular [Ca(2+)] oscillations.

Authors:  Alessandro Ustione; David W Piston
Journal:  Mol Endocrinol       Date:  2012-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.